Trilogy - Solutions/Service Company
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

Trilogy: Redefining the Standards of Medical Writing

Dr. Julia Forjanic Klapproth, Senior Partner, TrilogyDr. Julia Forjanic Klapproth, Senior Partner
Rudyard Kipling, a famous journalist and author of ‘The Jungle Book,’ once said, “Words are the most powerful drug used by humankind.” This quote reminds us that written content has the power to change behaviours and attitudes. In the case of medical writing, the stakes only get higher. The field of medicine is continuously updated with new knowledge and information by way of research studies, clinical experiments, and scientific innovation. All this data needs to be delivered effectively to all the stakeholders, including physicians, patients, consumers, and drug regulators. Trilogy—comprising some of the best medical writers in the world—goes beyond the general requirements when it comes to writing medical documents. With Trilogy, the clients avail content-driven sanity checks, a sense of ownership of the documents, and strategic support on all areas of document production.

Based in Frankfurt, Germany, the privately-owned company is driven by medical scientists and experts. Trilogy strives to provide the highest quality of writing in the shortest period of time. Every document produced by Trilogy is easy to understand and review, and tailored according to its target audience. The clear and concise medical writing significantly minimises the queries arising from regulatory assessors, prescribers, or patients. As a matter of fact, Trilogy also goes the extra mile in ensuring that drug approval and establishment are achieved at the quickest.

With Trilogy, the sponsors can rest assured of having the highest quality of documentation that is accurate as well as written to impress the regulators. In the interest of the safety of all concerned, medical therapies around the world are highly regulated. Before any new treatment is introduced into the market, it undergoes the most rigorous clinical trials. Clinical development of new pharmaceuticals, vaccines, medical devices, and therapies is a massive undertaking and requires the highest level of clinical documentation. Trilogy’s goal is to ensure that the reviewers and regulators make their approval decisions faster and more proactively.

Every document produced by Trilogy is easy to understand and review, and tailored according to its target audience

The task, however, does not end with the approvals. Even after approval, the sponsors or pharmaceutical organisations need to invest in their medical marketing as it will dictate the reaction of the target prescribers and patients. However, the medical sponsors might not have the adequate resources or expertise needed to develop concise, precise, and engaging medical writing, which again adds to the burden of the clinical team. In such cases, the sponsors can relieve their teams of the management and coordination burden of preparing the key clinical documentation by outsourcing it to Trilogy. With a dedicated writing team providing maximum continuity over the entire course of the project, the sponsors can highly expedite their medical marketing. Besides, the company also offers proactive support in ensuring project delivery on time and budget with its informed suggestions.

To understand Trilogy’s unique process, we can explore how the company helps its clients in expediting their clinical development process. Firstly, the company assigns a dedicated writing team, which assists the client’s clinical development group with its robust medical writing, project management, and quality control capabilities. To reduce document preparation time, Trilogy’s team conducts parallel processing of different sections of the document. As the process is supported by an entire team rather than an individual writer, Trilogy delivers continuous upkeep throughout the development process. Furthermore, the complementary skills and experiences of the team members strengthen the integrity and quality of the medical documentation, thus helping the clients overcome the regulatory challenges.

As a flexible and responsive company, Trilogy continuously adapts its approaches to counter the uncertainties involved in clinical development. By consolidating the diverse functions of the clinical development through the documentation process, Trilogy facilitates seamless coordination between the various teams involved in clinical development. The company is set to expand its capabilities further and augment its footing in the medical space. Trilogy is on the path of redefining medical writing, not only for the benefits of its clients but also for other stakeholders relevant to clinical development.
Share this Article:
Top 10 Clinical Trial Management Companies in Europe - 2020

Company
Trilogy

Headquarters
Frankfurt, Germany

Management
Dr. Julia Forjanic Klapproth, Senior Partner

Description
Trilogy provides medical writing and consulting services for clinical development sponsors all across the globe, thus helping them expedite the regulatory review process. With Trilogy, the clients avail content-driven sanity checks, a sense of ownership of the documents, and strategic support on all areas of document production. Based in Frankfurt, Germany, the privately-owned company is driven by medical scientists and experts. Trilogy strives to provide the highest quality of writing, while also ensuring the shortest period of document production. Every document produced by Trilogy is easy to understand and review, and tailored according to the target audience. The clear and concise medical writing significantly minimises the queries arising from regulatory assessors, prescribers, or patients

Trilogy